The launch of our ambitious new research strategy “Catalysing a Cure” outlines our continued commitment to our vision of a world free of MND.
It sets out our mission to fund, guide and enable the smartest, most efficient research to expedite the development of new treatments, and ultimately cure MND.
We will drive forward a focused portfolio of cutting-edge translational science, collaborate with all those who share our vision, explore opportunities to leverage more funding into MND research and encourage new ways of thinking to make progress together, faster.
Our strategy was developed in collaboration with over 100 people from all corners of the MND community, ensuring the needs and priorities of people affected by MND are at the heart of all our activities. You can find out more about how we developed our strategy here.
We support studies that robustly assess the potential of new targets for treatments, prioritising those with the most potential to underpin future therapeutic approaches.
We invest in pre-clinical studies and clinical trials to drive forward the development of new treatments, and help to fast-track those with the most promise towards the clinic.
We encourage research that will improve the translation of scientific discoveries from the lab to the clinic including earlier detection and diagnosis, better biomarkers and patient stratification.
In promising research through our competitive grant scheme and other strategic initiatives.
With all those who share our vision to pool funds and expertise, achieving greater impact together.
The political agenda and help shape the research landscape through our Scientific Advisory Meetings.
People affected by MND to ensure their needs are at the heart of all we do.
If you want to get involved in any of our research activities and are a researcher, funder or someone affected by MND, we’d love to hear from you.
Please get in touch at firstname.lastname@example.org.